• By ICR Secretariat
  • Posted Sunday, October 1, 2017

Kristen McLeod takes on the leadership of the Office for Life Sciences

The Department of Health and the Department for Business, Energy and Industrial Strategy are delighted to announce that Kristen McLeod will take up the post of Director of the Office for Life Sciences, effective 13th November 2017. Kristen has over a decade of experience working in health and across Whitehall, most recently as Director of Strategy at the Department of Health. After three-and-a-half years, Dr Nicole Mather has chosen not to renew her secondment to government. Nicole will continue collaborating with the life sciences industry leadership, as part of OLS through the Autumn, aiming to shape a Sector Deal by the end of 2017.
The Office for Life Sciences aims to build our life sciences industry into a global hub that makes the UK the home of clinical research and medical innovation, working closely with colleagues from inside and outside of government. Working across the research base and supporting growing companies and sector skills, OLS collaborates across the sector including with the DIT Life Sciences Organisation to enable trade and works with the NHS to improve access to evidence and innovation.
Over the last three and a half years the OLS has improved patient care with the Early Access to Medicines Scheme bringing products to patients faster and the Test Beds demonstrating digital innovations which can be integrated into patient pathways; contributed to a vision for the future of the uptake of innovation via the Accelerated Access Review; developed a strategy to increase manufacturing and exports in partnership with industry via the Medicines Manufacturing Industry Partnership; contributed to government’s approach to Brexit for the Life Sciences industries in consultation with industry colleagues; and latterly enabled the sector to develop a Life Sciences industrial strategy which we hope will be the basis for the first sector deal.
The OLS now has well-established links to a wide range of colleagues across government from NHS England to Dept for International Trade Life Sciences Organisation, UKRI, NICE and MHRA as well as across the regions which will stand UK Life Sciences in good stead for the future.